Glaxo Group Limited

Duncan Stuart Holmes

Keith Biggadike

Diane Mary Coe

John Liddle

Brian Edgar Looker

Panayiotis Alexandrou Procopiou

Paul Bamborough

Michael David Barker

Jeremy John Payne

John Martin Pritchard

Philip Charles Box

Caroline Whitworth

Sebastien Andre Campos

Heather Hobbs

Paul Faulder

Michael John Johnston

A compound of formula (I) or a salt, solvate, or physiologically functional derivative thereof, wherein: m is an integer of from 2 to 8; n is an integer of from 2 to 5; with the proviso that m+n is 4 to 10; Rand Rare independently selected from hydrogen and Calkyl with the proviso that the total number of carbon atoms in Rand Rnot more than 4; Rand Rare independently selected from hydrogen and Calkyl with the proviso that the total number of carbon atoms in Rand Ris not more than 4, and Aris a group selected from (a), (b), (c) and (d). 

Medicinal compounds

The present invention relates to compounds of formula (I) as defined herein and salts or solvates thereof. Processes for preparing these compounds and pharmaceutical formulations containing them are also disclosed, as well as methods for the prophylaxis of treatment of a clinical condition using such compounds.

[object Object]

Growing community of inventors

Stevenage, United Kingdom

Duncan Stuart Holmes